HMP Global December 11, 2024
After writing about Dr Oz’s potential impact on Medicare drug negotiations last week, I found myself diving deeper into an aspect of his nomination that deserves closer attention: his vision for Medicare’s future. A letter from Senate Democrats, led by Elizabeth Warren and Ron Wyden, raises critical questions about Dr Oz’s previous calls for Medicare privatization and his substantial financial ties to the insurance industry.
The heart of the matter isn’t just about one nominee’s stockholdings or past statements. It’s about the fundamental nature of Medicare itself. Having followed Senator Wyden’s work on Medicare policy for several years, I’ve seen how the program serves as an “ironclad promise” to seniors. That promise now faces a potential reshaping under new leadership.
...Today's Sponsors
Today's Sponsor